ClinicalTrials.gg
Drug

Gemcitabine-oxaliplatin regimen clinical trials

studies test it
28
open now
11
in phase 3
4
first study started
2004

How each study uses gemcitabine-oxaliplatin regimen is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the gemcitabine-oxaliplatin regimen studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

GEMOX
4
Gemzar
2
HAIC (GEMOX)
2
Gemcitabine-Oxaliplatin Regimen
1

Studies by the year they started

28 studies that test it; most in 2025 (4)

Studies that test gemcitabine-oxaliplatin regimen, by start year
YearStudies
20042
20071
20081
20091
20101
20121
20151
20182
20191
20203
20212
20221
20233
20242
20254
20262

Who runs them

Industry 4 · Other 24

Shanghai Zhongshan Hospital (2) · Asan Medical Center (2) · Zhejiang Cancer Hospital (2) · The First Affiliated Hospital with Nanjing Medical University (1) · Georgetown University (1) · Samsung Medical Center (1) · M.D. Anderson Cancer Center (1) · Gustave Roussy, Cancer Campus, Grand Paris (1)

Often tested with

Tested in the same studies.

Lenvatinib (3) · Toripalimab (3) · Camrelizumab (2) · Tislelizumab (2) · Immune checkpoint inhibitors (1) · Gemcitabine (1) · Modified FOLFOX6 Regimen (1) · Docetaxel (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2

Studies that test gemcitabine-oxaliplatin regimen.

Studies

Open first, then newest update. How each study uses gemcitabine-oxaliplatin regimen is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 28

See all 28 studies that test gemcitabine-oxaliplatin regimen →

Given beside what is tested · 6 — gemcitabine-oxaliplatin regimen is usual care or a partner of the new treatment
As the comparator · 1 — what is tested is compared with gemcitabine-oxaliplatin regimen